Innovate (VATE) shares soared nearly 61% amid heavy trading after the company said late Friday that the US Food and Drug Administration approved its MediBeacon platform to assess kidney function.
Over 17.4 million shares traded intraday versus a daily average of roughly 43,000.
Redwire (RDW) said Monday that it agreed to acquire Edge Autonomy in a cash and stock deal worth $925 million, expanding its space platforms portfolio.
Shares of Redwire advanced 43% as intraday trading volume soared to more than 7.9 million from a daily average of about 888,000.
Moderna (MRNA) disclosed late Friday a $590 million award by the US Department of Health and Human Services to accelerate the development of mRNA-based pandemic influenza vaccines.
Shares jumped 6.5%, with intraday trading volume rising to over 9.4 million compared with a daily average of about 9.1 million.
Price: 8.22, Change: +3.11, Percent Change: +60.86
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。